Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

view_cart
☰

Ponstan

Ponstan
In stock
250mg · 500mg
from A$32.64
Strength
Pack size — the bigger the pack, the cheaper the tablet
A$39.18A$32.64
A$1.09 per tablet

In brief

  • Available from pharmacies and online suppliers in many countries; Ponstan (mefenamic acid) is prescription-only in most jurisdictions but can be purchased without a prescription in some pharmacies and in some countries—availability varies by local regulation (in our pharmacy it is available without a prescription).
  • Ponstan is used for acute mild-to-moderate pain and primary dysmenorrhoea; it is a non-steroidal anti-inflammatory drug (a fenamate) that reduces pain by inhibiting prostaglandin synthesis via non‑selective cyclo‑oxygenase (COX) inhibition.
  • Usual adult dose: 500 mg initially, then 250 mg every 6 hours as required (maximum short‑term use, typically up to 1 week; for dysmenorrhoea usually 2–3 days per period).
  • Oral administration — tablets or capsules (commonly 250 mg; 500 mg in some markets); also oral suspension formulations exist for children in some countries.
  • Onset of pain relief is generally within about 30–60 minutes after oral dosing.
  • Duration of action is typically around 4–6 hours, which is why dosing is commonly every 6 hours as needed.
  • Avoid alcohol while taking Ponstan — alcohol increases the risk of gastrointestinal bleeding and may worsen drowsiness or dizziness.
  • The most common side effects are stomach pain and dyspepsia (nausea, vomiting, diarrhoea, constipation, headache and mild skin rashes are also reported).
  • Would you like to try ponstan without a prescription?

Critical Warnings & Restrictions

Basic Ponstan Information

  • INN (International Nonproprietary Name): Mefenamic acid
  • Brand Names Available In Australia: Not specified
  • ATC Code: M01AG01
  • Forms & Dosages: Capsules 250 mg; Tablets 250 mg, 500 mg; Oral suspension 50 mg/5 ml and 100 mg/5 ml (Asia)
  • Manufacturers In Australia: Not specified
  • Registration Status In Australia: Not specified
  • OTC / Rx Classification: Prescription-only (Rx) in most jurisdictions; some OTC availability in select Asian markets depending on formulation and country regulations

High‑Risk Groups (Elderly, Pregnancy, Chronic Illness)

Who should not take mefenamic acid is often the first question at the counter.

Absolute contraindications checklist:

  • Known allergy to mefenamic acid, NSAIDs or salicylates.
  • History of NSAID‑induced asthma, urticaria or allergic-type reactions.
  • Active peptic ulcer, gastrointestinal bleeding or chronic inflammatory GI disease.
  • Severe renal impairment or severe hepatic impairment.
  • Peri‑operative use for coronary artery bypass graft (CABG) pain.

Elderly guidance:

  • Elderly patients have higher risk of GI bleeding, renal injury and cardiovascular events.
  • Use the lowest effective dose for the shortest duration and consider safer alternatives where appropriate.

Pregnancy and Breastfeeding

  • First trimester: discuss risks with the prescriber before use.
  • Second trimester: discuss with prescriber; avoid if alternatives available.
  • Third trimester: avoid due to foetal and maternal risks (closure of ductus arteriosus and labour complications).
  • Breastfeeding: use with caution and seek advice from prescriber or pharmacist.

Interaction With Activities (Driving, Workplace Safety)

Mefenamic acid can cause dizziness, drowsiness or visual disturbance.

Avoid driving or operating heavy machinery until you know how the medicine affects you.

Worker safety assessment checklist (Australian WHS context):

  • Ask whether the worker feels drowsy, dizzy or has blurred vision after taking the dose.
  • Document counselling about impairment risk in the pharmacy record.
  • Advise any safety‑critical worker to avoid high‑risk tasks until unaffected.
  • Consider alternative analgesia if the role requires constant alertness.

Impairment Signs:

  • Drowsiness: feeling sleepy or less alert than normal.
  • Dizziness: lightheadedness or unsteadiness.
  • Blurred Vision: difficulty seeing clearly or focusing.

Q&A — Can I Drive After Taking It In Australia?

Q: Can I drive after taking mefenamic acid?

A: Not until you know how it affects you.

If you feel drowsy, dizzy or less alert, do not drive.

This advice aligns with Australian road safety and workplace laws, and pharmacists must counsel on impairment risk.

Usage Basics

INN, Brand Names Available In Australia

What is sold around the world helps identify a product at the pharmacy.

The international nonproprietary name is mefenamic acid.

Common international brand names include Ponstel, Meftal and Ponstan, and many generics are marketed simply as mefenamic acid.

Common forms sold internationally are 250 mg capsules/tablets for adults, 500 mg tablets in some markets, and paediatric suspensions in parts of Asia.

Brand Form Strength
To Be Filled From TGA ARTG To Be Filled From TGA ARTG To Be Filled From TGA ARTG

Legal Classification (TGA‑Approved, PBS‑Listed)

Classification varies by country and product registration.

In most jurisdictions mefenamic acid is prescription-only.

For Australia, always check the TGA ARTG for product registration and the PBS for subsidy status before advising patients.

Quick checklist for pharmacists:

  • Check ARTG entry for the specific brand and formulation.
  • Check PBS listing to see if the item is subsidised for the patient.
  • Follow state prescribing rules and local pharmacy protocols.

Dosing Guide

Standard Regimens (PBS Reference Dosing)

People commonly want to know how much to take and for how long.

Indication Initial Dose Maintenance Dose Max Duration
Acute Mild‑to‑Moderate Pain 500 mg 250 mg every 6 hours as needed Up to 1 week
Primary Dysmenorrhoea (Period Pain) 500 mg at onset of menses 250 mg every 6 hours for 2–3 days 2–3 days per cycle

Adjustments For Comorbidities

Not every patient can safely use the usual dose.

  • Children under 14 years: not recommended due to limited safety data.
  • Elderly: consider lower dose and monitor for GI bleeding and renal effects.
  • Renal impairment: contraindicated in severe impairment; avoid or reduce dose in mild‑to‑moderate cases and monitor renal function.
  • Hepatic impairment: avoid in severe cases and monitor liver function in mild‑to‑moderate disease.

Dose‑Reduction Triggers Checklist:

  • Advanced age (elderly).
  • Reduced renal function (abnormal eGFR).
  • History of peptic ulcer or GI bleeding.
  • Concomitant anticoagulant or antiplatelet therapy.

Q&A — What If I Miss A Dose?

Q: Missed a dose?

A: Take as soon as remembered unless the next dose is due soon.

Do not double dose to make up for a missed dose.

If unsure, contact the pharmacist or prescriber for advice.

Interaction Chart

Food And Drinks (Alcohol, Coffee, Australian Diet Context)

Simple dietary guidance helps reduce side effects.

  • Avoid alcohol while taking NSAIDs to reduce the risk of gastrointestinal bleeding and increased sedation.
  • Caffeine does not have a major pharmacological interaction but may worsen dyspepsia in sensitive patients.
  • Take with food to lower the chance of stomach upset.

Practical Counselling Points:

  • Avoid alcohol until treatment is finished.
  • Take the tablet with a meal or snack if you have a sensitive stomach.
  • Monitor for indigestion or abdominal pain, especially when consuming spicy or acidic foods common in many Australian diets.

Common Drug Conflicts

Major drug interactions affect safety and monitoring.

Drug Class Interaction Practical Advice
Anticoagulants / Antiplatelets (Warfarin, DOACs, Aspirin) Increased risk of bleeding Avoid combination where possible; if necessary monitor INR/bleeding and counsel patient
SSRIs Increased risk of gastrointestinal bleeding Advise caution and monitor for signs of GI bleed
ACE Inhibitors / ARBs / Diuretics Reduced renal function and possible loss of antihypertensive effect Monitor renal function and blood pressure; consider alternative analgesia
Methotrexate / Lithium Increased serum levels and toxicity risk Monitor levels and signs of toxicity; discuss with prescriber
Other NSAIDs / Aspirin Additive gastrointestinal and renal risks Do not combine multiple NSAIDs; avoid unless advised by prescriber

User Reports & Trends (Australia)

Patients often ask what others experience before trying a medicine.

  • Efficacy: many Australian reviewers report good relief for period pain and short‑term acute pain.
  • GI Side Effects: stomach upset, nausea and dyspepsia are common comments.
  • Cost Sensitivity: price and subsidy status influence which brand patients choose.
  • Pharmacist Trust: many Australians prefer pharmacist guidance over online selection alone.
  • Rural Access: rural patients report variable access to prescribers and brands, using telehealth and local pharmacies more often.

Balance anecdote with evidence and encourage reporting any suspected adverse reactions to the TGA Suspected Adverse Reaction portal.

Access & Purchase Options (Australia)

National Chains And Community Pharmacies

Where to go and what to bring speeds up service at the pharmacy.

  • Major chains that commonly dispense prescription NSAIDs include Chemist Warehouse, Priceline and TerryWhite Chemmart.
  • Community pharmacies will provide counselling and check for contraindications before supply.

What To Bring Checklist:

  • Valid prescription (if required).
  • List of current medicines, including OTC and supplements.
  • Pregnancy or breastfeeding status.
  • Allergy history, especially to NSAIDs or aspirin.

Online Pharmacies And Telehealth E‑Prescriptions

Telehealth makes access easier, especially for regional patients.

Many Australian telehealth services can issue e‑prescriptions for analgesics after assessment.

Online pharmacies may dispatch to metro and rural addresses; verify legitimate pharmacy registration and TGA/PBS processes.

Channel Typical Steps Access Issues (Rural)
Community Pharmacy Present prescription → pharmacist counselling → supply Generally available; same‑day supply in metro areas
Online Pharmacy Upload e‑prescription → pharmacist review → dispatch Delivery delays possible; check shipping times
Telehealth + Dispense Telehealth consult → e‑prescription → local or online dispense Good option for rural patients; allow extra time for delivery

In our online pharmacy, ponstan is available without a prescription, with discreet delivery to Australia in 9-21 days.

Mechanism & Pharmacology

Simplified Explanation

How the medicine works explains both benefit and side effects.

Mefenamic acid is a fenamate NSAID (ATC M01AG01) that inhibits cyclo‑oxygenase enzymes to reduce prostaglandin production.

Reducing prostaglandins lowers pain and inflammation and is particularly helpful for menstrual cramp pain.

  • COX‑1: enzyme involved in gastric protection and platelet function.
  • COX‑2: enzyme more linked to pain and inflammation.
  • Prostaglandins: chemical mediators that cause pain, fever and inflammation.
  • Fenamate: the chemical family to which mefenamic acid belongs.

Clinical Terms (Brief)

Understanding onset, metabolism and excretion is practical for counselling.

Pharmacology Term Plain English Meaning
Onset Typically within 30–60 minutes
Duration Depends on dose; repeat dosing every 6 hours is common
Metabolism Processed by the liver
Excretion Eliminated via the kidneys

The hepatic metabolism and renal excretion explain why liver or kidney impairment requires caution.

Indications & Off‑Label Uses

Approved Indications By TGA (Practical Note)

Check the ARTG for precise approved wording for each product.

  • Common approved uses internationally include acute mild‑to‑moderate pain and primary dysmenorrhoea (period pain).
  • For Australia, confirm the ARTG entry for exact approved indications and product information.

Common Approved Uses: acute pain, primary dysmenorrhoea.

Off‑Label Uses In Australian Clinical Practice

Mefenamic acid is sometimes used off‑label for short‑term musculoskeletal pain where NSAIDs are suitable.

Prescribers may prefer NSAIDs with better GI or cardiovascular profiles for longer courses.

Clinician Checklist For Off‑Label Use:

  • Obtain informed consent and document rationale.
  • Review comorbidities and current medications.
  • Use the shortest effective duration and monitor for adverse effects.

Key Clinical Findings (Evidence Summary)

Clinical evidence supports targeted uses but safety signals matter.

  • Efficacy: established for primary dysmenorrhoea and short‑term acute pain relief.
  • Common adverse events: gastrointestinal upset, nausea, headache, dizziness and skin rash.
  • High‑risk safety signals: GI bleeding, renal impairment and potential cardiovascular risks similar to other NSAIDs.
Study Population Finding
Placeholder To be populated with citations To be populated with findings

When publishing clinically focused material, cite Cochrane reviews, recent RCTs and national guidance such as NHMRC where relevant.

Alternatives Matrix

PBS‑Listed Alternatives Comparison Table

Drug Typical Dose PBS Subsidy Status Key Pros Key Cons
Ibuprofen 200–400 mg every 4–6 hours Check PBS for current listing OTC options; familiar dosing GI and renal risk with long‑term use
Naproxen 250–500 mg twice daily Check PBS for current listing Longer duration of action Similar GI/Cardio risks
Diclofenac 50 mg two to three times daily Check PBS for current listing Effective for musculoskeletal pain Cardiovascular risk considerations
Paracetamol 500–1000 mg every 4–6 hours (max 4 g/day) Usually not PBS for simple analgesia; check listings Lower GI risk; suitable for many patients Less effective for inflammatory pain

Update PBS subsidy columns from current PBS listings before publication.

Pros And Cons Checklist

  • GI Risk: highest with traditional NSAIDs; paracetamol preferred if GI risk is a major concern.
  • Cardiovascular Risk: consider patient cardiovascular history when choosing an NSAID.
  • Renal Monitoring: required for patients on ACE inhibitors, ARBs or diuretics.
  • Pregnancy/Breastfeeding: paracetamol is generally preferred; avoid mefenamic acid in late pregnancy.
  • OTC vs Rx: paracetamol and low‑dose ibuprofen often available OTC; mefenamic acid commonly prescription-only.

Common Questions (Australian Pharmacy FAQs)

Short answers for frequent consultations at the pharmacy counter.

  • Is it safe in pregnancy? Avoid in the third trimester; discuss first/second trimester with the prescriber.
  • Breastfeeding? Use with caution and seek specific advice from the prescriber or pharmacist.
  • Can I combine with paracetamol? Often acceptable for better pain relief, but check total medicines list and avoid doubling up on NSAIDs.
  • Timing with food? Take with food to reduce dyspepsia.
  • Signs of serious reaction: black/tarry stools, severe abdominal pain, shortness of breath, severe rash — seek urgent care.

Seek Immediate Help If:

  • There is vomiting blood or black/tarry stools.
  • Sudden severe shortness of breath or chest pain.
  • Sudden swelling of the face, lips or tongue.

Report suspected adverse effects to the TGA to help monitor safety in Australia.

Price & Access Comparison Table

Comparison Table — Pharmacy/Source, Typical Price Range, PBS Subsidy Status, Prescription Required

Source Typical Price Range PBS Subsidy Prescription Required
Chemist Warehouse Varies; check current price Verify on PBS Yes/No — verify product
Priceline Varies; check current price Verify on PBS Yes/No — verify product
Local Community Pharmacy Varies; check current price Verify on PBS Usually Yes
Online Pharmacy Varies; check current price Verify on PBS Depends on product and supply

Do not publish fixed prices; link to retailers for live pricing.

Access Checklist — Major Chains, Online Pharmacies, Rural Vs Urban Availability

  • Rural steps: telehealth consult → e‑prescription → local pharmacy dispense or online delivery.
  • Allow extra delivery time for remote areas and check shipping policies.
  • Ask about generics and PBS eligibility to get the best price.

Registration & Regulation (Australia)

TGA Approval

Always confirm the specific product registration before supply.

  • Search the ARTG for the exact product name and formulation.
  • Review the product information document for contraindications and dosing.
  • Confirm local approved indications and any product‑specific warnings.

PBS Subsidy Details

PBS listings and subsidy status change over time and must be checked before advising patients.

  • Search the PBS website for current listings and item codes.
  • Confirm patient eligibility such as concession cards for subsidies.
  • Link to PBS/eHealth resources in patient information where appropriate.

Storage & Handling

Household Storage In Australian Climate (Heat/Humidity)

Proper storage protects potency and safety in hot or humid regions.

  • Store at 20–25°C (68–77°F) and protect from moisture and heat.
  • Avoid storing medicines in the bathroom or near a heat source.
  • Keep in the original container with the child‑resistant cap and check expiry dates regularly.

Cold‑Chain Handling For Pharmacies

Mefenamic acid is not temperature sensitive like vaccines but still requires sensible handling.

  • Store at controlled room temperature in a dry area.
  • Follow supplier handling instructions and inspect packaging on receipt.
  • For extreme heat shipments, consider insulated packaging to avoid exposure during transport.

Guidelines For Proper Use (Pharmacist Counselling Style)

Australian Pharmacist Counselling Checklist

A short script helps keep consultations consistent and safe.

  • Confirm patient identity and allergy history.
  • Ask about pregnancy, breastfeeding and current medicines.
  • Explain indication, dose, frequency and maximum duration (short‑term only).
  • Warn about common adverse effects: GI upset, dizziness, rash.
  • Explain key interactions: anticoagulants, ACE inhibitors, SSRIs, lithium, methotrexate.
  • Advise what to do if a dose is missed or in case of overdose.
  • Document counselling in the pharmacy record and provide a written leaflet.

Patient Advice From PBS And National Health Authorities

Reinforce short‑term use and safety signals from authoritative sources.

  • Use for up to 1 week for acute pain and 2–3 days for dysmenorrhoea per cycle unless advised otherwise.
  • Seek medical review for worsening pain, signs of GI bleeding, breathlessness, swelling or oedema.
  • Report adverse effects to the TGA and ensure follow‑up where necessary.

Delivery Across Australia

City Region Delivery Time
Sydney New South Wales 9-14 days
Melbourne Victoria 9-14 days
Brisbane Queensland 9-14 days
Perth Western Australia 9-14 days
Adelaide South Australia 9-14 days
Canberra Australian Capital Territory 9-14 days
Hobart Tasmania 9-14 days
Darwin Northern Territory 9-14 days
Gold Coast Queensland 14-21 days
Newcastle New South Wales 14-21 days
Wollongong New South Wales 14-21 days
Geelong Victoria 14-21 days
Townsville Queensland 14-21 days

Related products